Catheter-Directed Thrombolysis of Peripheral Arterial Occlusions and Deep Vein Thrombosis

Introduction

This chapter describes the current status of catheter-directed lytic therapy for occlusive thrombi of arteries and veins. A recent international consensus document, concerning the use of lytic therapy for symptomatic lower extremity arterial thrombi, has been endorsed by several international societies.¹ A review of this document will serve to summarize current opinion on this topic. The present chapter addresses issues such as patient selection, techniques, and therapeutic efficacy. The techniques of arterial thrombolysis are being adapted to treat venous thrombi. Early results in the venous system are encouraging, but the long-term efficacy is yet to be established.

• References

• 1 The International Working Group. Thrombolysis in the management of lower limb peripheral arterial occlusion: A Consensus Document. Am J Cardiol 1998; 81: 207-218.
• 2 McNicol GB, Reid W, Bain WH, Douglas AS. Treatment of peripheral arterial occlusions by streptokinase perfusion. Br Med J 1963; 1: 1508-1512.
• 3 Dotter CT, Rosch J, Seaman AJ. Selective clot lysis with low-dose streptokinase. Radiology 1974; 111: 31-37.
• 4 McNamara TO, Fischer JR. Thrombolysis in peripheral arterial and graft occlusions: improved results using high dose urokinase. AJR 1985; 144: 764-775.
• 5 Belli A-M. Thrombolysis in the peripheral vascular system. Cardvasc Intervent Radiol 1998; 21: 95-101.
• 6 Bowles CR, Olcott C, Pakter RL, Lombard C, Mehigan JT, Walter JF. Diffuse arterial narrowing as a result of intimal proliferation: a delayed complication of embolectomy with the Fogarty balloon catheter. J Vasc Surg 1988; 7: 487-494.
• 7 McNamara TO, Bomberger RA. Factors affecting initial and six-month patency rates after intra-arterial thrombolysis with high dose urokinase. Am J Surg 1986; 152: 709-712.
• 8 Luppatelli L, Barzi F, Corneli P, Lemmi A, Mosca S. Selective thrombolysis with low-dose urokinase in chronic arteriosclerotic occlusions. Cardiovasc Intervent Radiol 1988; 11: 123-126.
• 9 Ikeda Y, Rummel MC, Field CK, Bhatnagar PK, Khoury PA, Wilson AR, Kerstein MD, Matsumoto T. Relationship of runoff vessels to results following thrombolysis and revascularization for synthetic graft occlusions. Am Surg 1995; 61: 481-485.
• 10 Sandbaek G, Staxrud LE, Rosen L, Bay D, Stiris M, Gjolberg T. Factors predicting the outcome of intraarterial thrombolysis in peripheral arterial and graft occlusions. Acta Radiologica 1996; 37: 299-304.
• 11 Ouriel K, Veith FJ. Acute lower limb ischemia; determinants of outcome. Surgery 1998; 124: 336-342.
• 12 Gardiner GA, Koltun W, Kandarpa K, Whittemore A, Meyerovitz MF, Bettmann MA, Levin DC, Harrington DP. Thrombolysis of occluded femoropopliteal grafts. AJR 1986; 147: 621-626.
• 13 Sullivan KL, Gardiner GA, Kandarpa K, Bonn J, Shapiro MJ, Carabasi RA, Smullens S, Levin DC. Efficacy of thrombolysis in infrainguinal bypass grafts. Circulation 1991; 83 (sI) I-99-I-105.
• 14 Spence LD, Hartnell GG, Reinking G, McEniff N, Gibbons G, Pomposelli F, Clouse ME. Thrombolysis of infrapopliteal bypass grafts. AJR 1997; 169: 717-721.
• 15 Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19: 1021-1030.
• 16 McNamara TO. Thrombolysis as an alternative initial therapy for the acutely ischemic limb. Seminars Vasc Surg 1992; 5: 89-98.
• 17 Huetll EA, Soulen MC. Thrombolysis of lower extremity embolic occlusions: a study of the results of the STAR registry. JVIR 1995; 197: 141-145.
• 18 Wholey MH, Maynar MA, Wholey MH, Pulido-Duque JM, Reyes R, Jarmolowski CR, Castaneda WR. Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Cath Cardiovasc Diagn 1998; 44: 159-169.
• 19 Graor RA, Olin J, Bartholomew JR, Ruschhaupt WF, Young JR. Efficacy and safety of intraarterial local infusion of streptokinase, urokinase, or tissue plasminogen activator for peripheral arterial occlusion: a retrospective review. J Vasc Med Biol 1990; 2: 310-315.
• 20 Woo KS, White HD. Comparative tolerability profiles of thrombolytic agents: a review. Drug Safety 1993; 8: 19-29.
• 21 Braithwaite BD, Davies B, Birch PA, Heather BP, Earnshaw JJ. Management of acute leg ischemia in the elderly. Br J Surg 1998; 85: 217-220.
• 22 McNamara TO, Goodwin SC, Kandarpa K. Complications associated with thrombolysis. Seminars in Interventional Radiology 1994; 2: 134-144.
• 23 Haimovici H. Arterial embolism with acute massive ischemic myopathy and myoglobinuria. Surgery 1960; 47: 739-747.
• 24 Beyersdorf F, Matheis G, Kruger S, Hanselmann A, Freisleben HG, Zimmer G, Satter P. Avoiding reperfusion injury after revascularization: experimental observations and recommendations for clinical application. J Vasc Surg 1989; 9: 757-766.
• 25 Gardiner GA, Sullivan KL. Complications of regional thrombolytic therapy. In: Kadir S. (ed.) Current Practice of Interventional Radiology. BC Decker, Philadelphia, PA: BC Decker; 1991: 87-91.
• 26 Sullivan KL, Gardiner GA, Shapiro MJ, Bonn J, Levin DC. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 1989; 173: 805-808.
• 27 Kandarpa K, Chopra PS, Aruny JE, Polak JF, Donaldson MC, Whittemore AD, Mannick JA, Goldhaber SZ, Meyerovitz MF. Intraarterial thrombolysis of lower extremity occlusions: a prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology 1993; 188: 861-867.
• 28 Valji K, Roberts AC, Davis GB, Bookstein JJ. Pulsed-spray thrombolysis of arterial and bypass graft occlusions. AJR 1991; 156: 617-621.
• 29 Ogilby JD, Kopelman HA, Klein LW, Agarwal JB. Adequate heparinization during PTCA: assessment using activated clotting times. Cath and Cardiovasc Diagn 1989; 18: 206-209.
• 30 Marder VJ. Relevance of changes in blood fibrinolytic and coagulation parameters during thrombolytic therapy. Am J Med 1987; 83 2A0 15-19.
• 31 Valji K, Bookstein JJ. Fibrinolysis with Intrathrombic intrathrombic Injection injection of Urokinase urokinase and Tissuetissue-type Plasminogen plasminogen Activatoractivator: results in a new model of subacute venous thrombosis. Invest Radiol 1987; 22: 23-27.
• 32 Kandarpa K, Drinker PA, Singer SJ, Caramore D. Forceful pulsatile local infusion of enzyme accelerates thrombolysis: in vivo evaluation of a new delivery system. Radiology 1988; 168: 739-744.
• 33 Cragg AH, Smith TP, Corson JD, Nakagawa N, Castaneda F, Kresowik TF, Sharp WJ, Shamma A, Berbaum KS. Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial. Radiology 1991; 178: 681-686.
• 34 Meyerovitz MF, Goldhaber SZ, Reagan K, Polak JF, Kandarpa K, Grassi CJ, Donovan BC, Bettmann MA, Harrington DP. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology 1990; 175: 75-78.
• 35 Hirshberg A, Schneiderman J, Garniek A, Walden R, Morag B, Thomson SR, Adar R. Errors and pitfalls in intraarterial thrombolytic therapy. J Vasc Surg 1989; 10: 612-616.
• 36 Eskridge JM, Becker GJ, Rabe FE, Richmond BD, Holden RW, Yune HY, Klatte EC. Catheter-related thrombosis and fibrinolytic therapy. Radiology 1983; 149: 429-432.
• 37 Baglin TP, Luddington R, Jennings I, Richards EM. Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator. The Lancet 1993; 341: 504-505.
• 38 Van Breda A, Groar RA, Katzen BT, Risius B, Gillings D. Relative cost-effectiveness of urokinase versus streptokinase in the treatment of peripheral vascular disease. JVIR 1991; 2: 77-87.
• 39 Graor RA, Olin J, Bartholomew JR. et al. Efficacy and safety of intraarterial local infusion of streptokinase, urokinase, or tissue plasminogen activator for peripheral arterial occlusion: a retrospective review. J Vasc Med Biol 1990; 2: 310-315.
• 40 Clouse ME, Stokes KR, Perry LJ, Wheeler HG. Percutaneous intraarterial thrombolysis: analysis of factors affecting outcome. JVIR 1994; 5: 93-100.
• 41 Van Breda A. Katzen BT, Deutsch AS. Urokinase versus streptokinase in local thrombolysis. Radiology 1987; 165: 109-111.
• 42 Graor RA, Olin JW. Regional thrombolysis in peripheral arterial occlusions. In: Julian D, Kubler W, Norris RM, Swan HJC, Collen D, Verstraete M. eds. Thrombolysis in Cardiovascular Disease. New York: Marcel Dekker, Inc.; 1989: 381-395.
• 43 The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220: 251-268.
• 44 Durham JD, Rutherford RB. Assessment of long-term efficacy of fibrinolytic therapy in the ischemic extremity. Semin Intervent Radiol 1992; 9: 166-173.
• 45 Cohen JR, Mannick JA, Couch NP, Whittemore AD. Recognition and management of impending graft failure. Arch Surg 1986; 121: 758-759.
• 46 Lammer J, Pilger E, Neumayer K, Schreyer H. Intraarterial fibrinolysis: long-term results. Radiology 1986; 161: 159-163.
• 47 Diffin DC, Kandarpa K. Assessment of peripheral intraarterial thrombolysis versus surgical revascularization in acute lower-limb ischemia: a review of limb-salvage and mortality statistics. JVIR 1996; 7: 57-63.
• 48 Faggioli GL, Peer RM, Pedrini L, DiPaola MD, Upson JA, D’Addato M, Ricotta JJ. Failure of thrombolytic therapy to improve long-term vascular patency. J Vasc Surg 1994; 19: 289-297
• 49 McNamara TO, Bomberger RA, Merchant RF. Intraarterial urokinase as the initial therapy for acutely ischemic limbs. Circulation 1991; 83 (suppl) 106-119.
• 50 Ouriel K, Shortell CK, Azodo MVU, Guiterrez OH, Marder VJ. Acute peripheral arterial occlusion: predictors of success in catheter-directed thrombolytic therapy. Radiology 1994; 193: 561-566.
• 51 Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery (TOPAS): Phase I results. J Vasc Surg 1996; 23: 64-73.
• 52 Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment of acute arterial occlusions of legs. N Engl J Med 1998; 338: 1105-1111.
• 53 Ouriel K, Kolassa M, DeWeese JA, Green RM. Economic implications of thrombolysis or operation as the initial treatment modality in acute peripheral arterial occlusion. Surgery 1995; 118: 810-814.
• 54 Starck EE, McDermott JC, Crummy AB, Turnipseed WD, Acher CW, Burgess JH. Percutaneous aspiration thromboembolectomy. Radiology 1985; 156: 61-66.
• 55 Stoughton J, Ouriel K, Shortell CK, Cho J, Marder VJ. Plasminogen acceleration of urokinase thrombolysis. J Vasc Surg 1994; 19: 298-305.
• 56 Yuji S, Kilgore KS, Lucchesi BR. Monoclonal antibody [7E3 F(ab’)₂] prevents arterial but not venous thrombosis. J Cardiovasc Pharm 1995; 26: 241-250.
• 57 Gryglewski RJ, Korbut R, Swies J, Kostka Trabka E, Bieron K, Robak J. Thrombolytic action of ticlopidine: possible mechanisms. Eur J Pharm 1996; 308: 61-67.
• 58 Hirsh J, Hoak J. Management of deep venous thrombosis and pulmonary embolism. Circulation 1996; 93: 2212-2245.
• 59 Krupski WC, Bass A, Dilley RB, Bernstein EF, Otis SM. Propagation of deep venous thrombosis identified by duplex ultrasonography. J Vasc Surg 1990; 12: 467-475.
• 60 Hull RD, Raskob GE, Rosenblum D, Pineo GF, Lerner RG, Gafni A, Trowbridge AA, Elliott CG, Green D, Feinglass J. Treatment of proximal vein thrombosis with SQ low-molecular weight heparin versus IV heparin. Arch Intern Med 1997; 157: 289-294.
• 61 Johnson BF, Manzo RA, Bergelin RO, Strandness DE. Relationship between changes in the deep venous system and the development of post thrombotic syndrome after an acute episode of lower limb deep vein thrombosis: A a one- to six-year follow-up. J Vasc Surg 1995; 21: 307-313.
• 62 Labropoulos N, Volteas N, Leon M, Sowade O, Rulo A, Giannoukas AD, Nicolaides AN. The Role of venous outflow obstruction in patients with chronic venous dysfunction. Arch Surg 1997; 132: 46-51.
• 63 Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness Jr. DE. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596-608.
• 64 Breddin HK. Treatment of deep vein thrombosis: Is is thrombosis regression a desirable endpoint?. Semininars in Thrombosis and Hemostasis 1997; 23: 179-183.
• 65 Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393-397.
• 66 Goldhaber SZ, Meyerovitz MF, Green D, Vogelzang RL, Citrin P, Heit J, Sobel M, Wheeler HB, Plante D, Kim H. et al. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990; 88: 235-240.
• 67 Camerota A, Aldrigde BC. Thrombolytic therapy for deep venous thrombosis: a critical review. Can J Surg 1993; 36: 359-364.
• 68 Eichlisberger R, Frauchiger B, Windmer MT, Widmer LK, Jager K. Late sequelae of deep venous thrombosis: a 13-year follow-up of 223 patients. Vasa 1994; 23: 234-243.
• 69 Gloor B, Muller M, Largiader J. Treatment concept in deep pelvic-leg venous thrombosis. Swiss Surg 1996; 3: 78-86.
• 70 Markel A, Manzo RA, Strandness DE. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med 1992; 152: 1265-1267.
• 71 Caspary L, Creutzig A, Alexander K. How often is thrombolytic therapy of deep pelvic-leg venous thrombosis indicated?. Med Klin 1995; 90: 618-622.
• 72 Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487-494.
• 73 Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol 1997; 7: 996-1001.
• 74 Camerota AJ. Thrombolytic therapy for acute deep vein thrombosis. In: Camerota AJ. ed. Thrombolytic Therapy for Peripheral Vascular Disease. Camerota AJ. Ed. Philadelphia: J.B. Lippincott; 1995: 175-195.
• 75 Heymans S, Verhaeghe R, Stockx L, Collen D. Feasibility study of catheter-directed thrombolysis with recombinant staphylokinase in deep venous thrombosis. Thromb Haemost 1998; 79: 517-519.
• 76 Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep vein thrombosis: report of a National Multi-center Registry. Radiology 1999; 211: 39-49.
• 77 Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz Jr. CA, Caldwell MD, Key NS, Hirsch AT, Hunter DW. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. JVIR 1997; 8: 405-418.